Combining serological assays and official statistics to describe the trajectory of the COVID-19 pandemic: results from the EPICOVID19-RS study in Rio Grande do Sul (Southern Brazil)
Fernando P. Hartwig, Luís Paulo Vidaletti, Aluísio J. D. Barros, Gabriel D. Victora, Ana M. B. Menezes, Marilia A. Mesenburg, Bernardo L. Horta, Mariângela F. Silveira, Cesar G. Victora, Pedro C. Hallal, Claudio J. Struchiner
doi: https://doi.org/10.1101/2021.05.21.21257634
Fernando P. Hartwig
1Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil
Luís Paulo Vidaletti
2International Center for Equity in Health, Federal University of Pelotas, Pelotas, Brazil
Aluísio J. D. Barros
1Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil
2International Center for Equity in Health, Federal University of Pelotas, Pelotas, Brazil
Gabriel D. Victora
3Laboratory of Lymphocyte Dynamics, Rockefeller University, New York, NY, United States
Ana M. B. Menezes
1Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil
Marilia A. Mesenburg
1Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil
4Federal University of Health Sciences of Porto Alegre, Porto Alegre, RS, Brazil
Bernardo L. Horta
1Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil
Mariângela F. Silveira
1Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil
Cesar G. Victora
1Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil
2International Center for Equity in Health, Federal University of Pelotas, Pelotas, Brazil
Pedro C. Hallal
1Postgraduate Program in Epidemiology, Federal University of Pelotas, Pelotas, Brazil
Claudio J. Struchiner
5Getúlio Vargas Foundation, Rio de Janeiro, Brazil
Posted May 24, 2021.
Combining serological assays and official statistics to describe the trajectory of the COVID-19 pandemic: results from the EPICOVID19-RS study in Rio Grande do Sul (Southern Brazil)
Fernando P. Hartwig, Luís Paulo Vidaletti, Aluísio J. D. Barros, Gabriel D. Victora, Ana M. B. Menezes, Marilia A. Mesenburg, Bernardo L. Horta, Mariângela F. Silveira, Cesar G. Victora, Pedro C. Hallal, Claudio J. Struchiner
medRxiv 2021.05.21.21257634; doi: https://doi.org/10.1101/2021.05.21.21257634
Combining serological assays and official statistics to describe the trajectory of the COVID-19 pandemic: results from the EPICOVID19-RS study in Rio Grande do Sul (Southern Brazil)
Fernando P. Hartwig, Luís Paulo Vidaletti, Aluísio J. D. Barros, Gabriel D. Victora, Ana M. B. Menezes, Marilia A. Mesenburg, Bernardo L. Horta, Mariângela F. Silveira, Cesar G. Victora, Pedro C. Hallal, Claudio J. Struchiner
medRxiv 2021.05.21.21257634; doi: https://doi.org/10.1101/2021.05.21.21257634
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (708)
- Anesthesia (201)
- Cardiovascular Medicine (2936)
- Dermatology (249)
- Emergency Medicine (439)
- Epidemiology (12740)
- Forensic Medicine (12)
- Gastroenterology (827)
- Genetic and Genomic Medicine (4579)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2914)
- Health Policy (1069)
- Hematology (388)
- HIV/AIDS (924)
- Medical Education (425)
- Medical Ethics (115)
- Nephrology (468)
- Neurology (4346)
- Nursing (236)
- Nutrition (638)
- Oncology (2268)
- Ophthalmology (645)
- Orthopedics (258)
- Otolaryngology (324)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (495)
- Public and Global Health (6932)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (487)
- Toxicology (60)
- Transplantation (210)
- Urology (180)